References
  1. Doganay M, Aygen B. Human brucellosis: an overview. Int J Infect Dis 2003;7:173–182
  2. Un cas de méningite mélitococcique, Soc méd Rp Paris, 1924, vol. 48 (pg. 1636-44)
  3. Falagas ME, Bliziotis IA. Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies. Antimicrob Agents Chemother 2006;50:22–33.
  4. Konstantopoulou, Kallirroi, et al. ”A comparative study between clinical grading of anterior chamber flare and flare reading using the Kowa laser flare meter.” International ophthalmology 35.5 (2015): 629-633.‏
  5. Karapinar B, Yilmaz D, Vardar F, Demircioglu O, Aydinok Y. Unusual presentation of brucellosis in a child: acute blindness, Acta Paediatr, 2005, vol. 94 (pg. 378-80).
  6. Al-Kharashi, Abdullah S. ”Endogenous endophthalmitis caused by Brucella melitensis.” Retinal Cases and Brief Reports 10.2 (2016): 165-167.‏Golshani, Maryam, and Saeid Buozari. ”A review of brucellosis in Iran: epidemiology, risk factors, diagnosis, control, and prevention.” Iranian biomedical journal 21.6 (2017): 349.‏
  7. Oray, Merih, et al. ”Endogenous Brucella endophthalmitis: A case report.” Saudi Journal of Ophthalmology 31.2 (2017): 106-108.‏
  8. Cullen, Cheryl L., and Aubrey A. Webb. ”Ocular manifestations of systemic disease.” Essentials of Veterinary Ophthalmology 463 (2008).‏
  9. Cavallaro N, Randone A, La Rosa L, Mughinin L. Bilateral papilledema in a patient with brucellosis. Metab Pediatr Syst Ophthalmol. 1990;13:115–8.
  10. Lashay AR, Manaviat MR, Azimi R, Riazi M. Ocular complications of Brucellosis. Bina J Ophthalm. 2003;4:345–48.
  11. Chee, Soon-Phaik, and Aliza Jap. ”Endogenous endophthalmitis.” Current opinion in ophthalmology 12.6 (2001): 464-470.‏
  12. Varshochi M, Majidi J, Amini M, Ghabili K, Shoja MM. False positive seroreactivity to brucellosis in tuberculosis patients: a prevalence study. International journal of general medicine. 2011 Mar 14:207-10.